Trials / Completed
CompletedNCT01114854
A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Supernus Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This multi-center, two-treatment study compares the pharmacokinetic profiles of Immediate Release (IR) and Modified Release (MR) formulations of Topiramate (TPM) in patients with epilepsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Topiramate IR | |
| DRUG | Topiramate ER |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2010-12-01
- Completion
- 2011-01-01
- First posted
- 2010-05-03
- Last updated
- 2017-05-18
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01114854. Inclusion in this directory is not an endorsement.